Xtant Medical (XTNT) Institutional Ownership $0.66 +0.02 (+3.24%) Closing price 04:10 PM EasternExtended Trading$0.67 +0.01 (+1.00%) As of 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Xtant Medical (NYSEAMERICAN:XTNT)CurrentInstitutional OwnershipPercentage69.33%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$45.99KNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$126.53K Get XTNT Insider Trade Alerts Want to know when executives and insiders are buying or selling Xtant Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XTNT Institutional Buying and Selling by Quarter Xtant Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/13/2025 Altium Capital Management LLC7,252,998$3.41M8.2%-2.2%5.218% 2/13/2025 Renaissance Technologies LLC798,033$354K0.0%+15.0%0.574% 2/5/2025 AMH Equity Ltd77,198$34K0.0%-59.5%0.056% 11/16/2024 Geode Capital Management LLC515,006$348K0.0%+70.2%0.370% 10/21/2024 Evernest Financial Advisors LLC40,000$27K0.0%N/A0.031% 8/20/2024 Nantahala Capital Management LLC3,580,000$2.26M0.1%-10.5%2.748% 8/9/2024 Renaissance Technologies LLC703,810$443K0.0%-7.8%0.540% 5/16/2024 AWM Investment Company Inc.378,206$443K0.1%-19.3%0.290% 5/16/2024 Juniper Investment Company LLC348,399$408K0.2%N/A0.268% 5/10/2024 Vanguard Group Inc.1,548,312$1.81M0.0%+3.2%1.189% Get the Latest News and Ratings for XTNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter. 5/7/2024 AMH Equity Ltd500,000$585K0.6%-15.8%0.384% 11/14/2023 AWM Investment Company Inc.468,680$516K0.1%N/A0.364% 11/6/2023 Sterling Investment Advisors Ltd.34,928$38K0.0%N/A0.027% 11/6/2023 AMH Equity Ltd594,029$653K0.8%N/A0.461% 10/25/2023 Crescent Grove Advisors LLC212,024$233K0.0%-19.1%0.164% 5/16/2023 Altium Capital Management LP6,227,559$3.97M2.2%-0.3%5.719% 5/1/2023 Virtu Financial LLC75,240$48K0.0%N/A0.069% 10/27/2022 CWM LLC100,000$72K0.0%N/A0.092% 7/20/2022 Crescent Grove Advisors LLC262,024$136K0.0%+61.7%0.300% 5/11/2022 Midwest Professional Planners LTD.40,744$28K0.0%N/A0.047% 1/24/2022 Crescent Grove Advisors LLC162,024$91K0.0%N/A0.187% 11/17/2021 Altium Capital Management LP6,254,458$6.94M1.5%-24.6%7.213% 11/12/2021 Renaissance Technologies LLC680,800$756K0.0%-32.7%0.785% 9/17/2021 Virtu Financial LLC36,613$60K0.0%N/A0.042% 8/17/2021 Price T Rowe Associates Inc. MD15,472$25K0.0%-44.5%0.018% 8/17/2021 Bridgeway Capital Management LLC290,902$474K0.0%-21.9%0.336% 8/13/2021 Renaissance Technologies LLC1,012,000$1.65M0.0%+9.8%1.167% 8/13/2021 Altium Capital Management LP8,292,602$13.52M3.1%N/A9.564% 5/18/2021 Millennium Management LLC11,786$28K0.0%-36.3%0.014% 5/18/2021 Orbimed Advisors LLC72,873,494$171.98M1.6%+0.1%84.046% 5/18/2021 Citadel Advisors LLC91,973$217K0.0%+37.2%0.106% 5/17/2021 Price T Rowe Associates Inc. MD27,900$66K0.0%N/A0.032% 5/17/2021 HRT Financial LP21,326$50K0.0%N/A0.025% 5/13/2021 Renaissance Technologies LLC921,771$2.18M0.0%+46.9%1.063% 5/12/2021 Geode Capital Management LLC21,204$50K0.0%N/A0.024% (Data available from 1/1/2016 forward) XTNT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XTNT shares? During the previous two years, 12 institutional investors and hedge funds held shares of Xtant Medical. The most heavily invested institutionals were Altium Capital Management LP ($3.97M), Altium Capital Management LLC ($3.41M), Nantahala Capital Management LLC ($2.26M), Vanguard Group Inc. ($1.81M), AWM Investment Company Inc. ($443K), Juniper Investment Company LLC ($408K), and Renaissance Technologies LLC ($354K).Learn more on XTNT's institutional investors. What percentage of Xtant Medical stock is owned by institutional investors? 69.33% of Xtant Medical stock is owned by institutional investors. Learn more on XTNT's institutional investor holdings. Which institutional investors have been buying Xtant Medical stock? The following institutional investors have purchased Xtant Medical stock in the last 24 months: AMH Equity Ltd ($594.03K), AWM Investment Company Inc. ($468.68K), Juniper Investment Company LLC ($348.40K), Geode Capital Management LLC ($212.39K), Renaissance Technologies LLC ($103.83K), Vanguard Group Inc. ($48.32K), and Evernest Financial Advisors LLC ($40K). How much institutional buying is happening at Xtant Medical? Institutional investors have bought a total of 1,850,574 shares in the last 24 months. This purchase volume represents approximately $45.99K in transactions. Which Xtant Medical major shareholders have been selling company stock? The following institutional investors have sold Xtant Medical stock in the last 24 months: Nantahala Capital Management LLC ($420K), AMH Equity Ltd ($207.33K), Altium Capital Management LLC ($162.42K), AWM Investment Company Inc. ($90.47K), Renaissance Technologies LLC ($59.50K), Crescent Grove Advisors LLC ($50K), and Altium Capital Management LP ($18.73K). How much institutional selling is happening at Xtant Medical? Institutional investors have sold a total of 1,008,452 shares in the last 24 months. This volume of shares sold represents approximately $138.47K in transactions. Related Companies FULC Institutional Ownership AURA Institutional Ownership RNAC Institutional Ownership ATAI Institutional Ownership CYRX Institutional Ownership TSVT Institutional Ownership AQST Institutional Ownership TERN Institutional Ownership DBVT Institutional Ownership MNPR Institutional Ownership This page (NYSEAMERICAN:XTNT) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored“Market Wizard” signals rare opportunityThe Fed Is Losing Control — What Comes Next Will Shock Traders The Fed is stuck — rising inflation and risi...Brownstone Research | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored How much money will YOU make when gold hits $5,000?What if I told you there was a way to secure a shot at making asymmetric gains from gold’s current historic bu...Eagle Publishing | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtant Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xtant Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.